377 related articles for article (PubMed ID: 27358035)
1. Deleting myeloid IL-10 receptor signalling attenuates atherosclerosis in LDLR-/- mice by altering intestinal cholesterol fluxes.
Stöger JL; Boshuizen MC; Brufau G; Gijbels MJ; Wolfs IM; van der Velden S; Pöttgens CC; Vergouwe MN; Wijnands E; Beckers L; Goossens P; Kerksiek A; Havinga R; Müller W; Lütjohann D; Groen AK; de Winther MP
Thromb Haemost; 2016 Aug; 116(3):565-77. PubMed ID: 27358035
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.
Adamson SE; Polanowska-Grabowska R; Marqueen K; Griffiths R; Angdisen J; Breevoort SR; Schulman IG; Leitinger N
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1020-1029. PubMed ID: 29599136
[TBL] [Abstract][Full Text] [Related]
4. Prevention of oxLDL uptake leads to decreased atherosclerosis in hematopoietic NPC1-deficient Ldlr
Jeurissen MLJ; Walenbergh SMA; Houben T; Gijbels MJJ; Li J; Hendrikx T; Oligschlaeger Y; van Gorp PJ; Binder CJ; Donners MMPC; Shiri-Sverdlov R
Atherosclerosis; 2016 Dec; 255():59-65. PubMed ID: 27816810
[TBL] [Abstract][Full Text] [Related]
5. Myeloid Deletion of α1AMPK Exacerbates Atherosclerosis in LDL Receptor Knockout (LDLRKO) Mice.
Cao Q; Cui X; Wu R; Zha L; Wang X; Parks JS; Yu L; Shi H; Xue B
Diabetes; 2016 Jun; 65(6):1565-76. PubMed ID: 26822081
[TBL] [Abstract][Full Text] [Related]
6. Myeloid
Melton EM; Li H; Benson J; Sohn P; Huang LH; Song BL; Li BL; Chang CCY; Chang TY
J Biol Chem; 2019 Oct; 294(43):15836-15849. PubMed ID: 31495784
[TBL] [Abstract][Full Text] [Related]
7. Myeloid cell-specific ATP-binding cassette transporter A1 deletion has minimal impact on atherogenesis in atherogenic diet-fed low-density lipoprotein receptor knockout mice.
Bi X; Zhu X; Gao C; Shewale S; Cao Q; Liu M; Boudyguina E; Gebre AK; Wilson MD; Brown AL; Parks JS
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1888-99. PubMed ID: 24833800
[TBL] [Abstract][Full Text] [Related]
8. SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway.
Wu N; Li RQ; Li L
Biochem Biophys Res Commun; 2018 Jun; 501(2):343-350. PubMed ID: 29567472
[TBL] [Abstract][Full Text] [Related]
9. Macrophage ABCA2 deletion modulates intracellular cholesterol deposition, affects macrophage apoptosis, and decreases early atherosclerosis in LDL receptor knockout mice.
Calpe-Berdiel L; Zhao Y; de Graauw M; Ye D; van Santbrink PJ; Mommaas AM; Foks A; Bot M; Meurs I; Kuiper J; Mack JT; Van Eck M; Tew KD; van Berkel TJ
Atherosclerosis; 2012 Aug; 223(2):332-41. PubMed ID: 22748276
[TBL] [Abstract][Full Text] [Related]
10. Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr
Zhao L; Cozzo AJ; Johnson AR; Christensen T; Freemerman AJ; Bear JE; Rotty JD; Bennett BJ; Makowski L
Atherosclerosis; 2017 Nov; 266():182-189. PubMed ID: 29035781
[TBL] [Abstract][Full Text] [Related]
11. Myeloid A disintegrin and metalloproteinase domain 10 deficiency modulates atherosclerotic plaque composition by shifting the balance from inflammation toward fibrosis.
van der Vorst EP; Jeurissen M; Wolfs IM; Keijbeck A; Theodorou K; Wijnands E; Schurgers L; Weber S; Gijbels MJ; Hamers AA; Dreymueller D; Rose-John S; de Winther MP; Ludwig A; Saftig P; Biessen EA; Donners MM
Am J Pathol; 2015 Apr; 185(4):1145-55. PubMed ID: 25659879
[TBL] [Abstract][Full Text] [Related]
12. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
[TBL] [Abstract][Full Text] [Related]
13. Orp8 deficiency in bone marrow-derived cells reduces atherosclerotic lesion progression in LDL receptor knockout mice.
van Kampen E; Beaslas O; Hildebrand RB; Lammers B; Van Berkel TJ; Olkkonen VM; Van Eck M
PLoS One; 2014; 9(10):e109024. PubMed ID: 25347070
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine-1-Phosphate Receptor 1, Expressed in Myeloid Cells, Slows Diet-Induced Atherosclerosis and Protects against Macrophage Apoptosis in Ldlr KO Mice.
Gonzalez L; Qian AS; Tahir U; Yu P; Trigatti BL
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29244772
[TBL] [Abstract][Full Text] [Related]
15. Macrophage Lxrα reduces atherosclerosis in Ldlr
Yin Y; Zeng S; Li Y; Wu Z; Huang D; Gao P
Biochem Biophys Res Commun; 2020 Aug; 529(3):540-547. PubMed ID: 32736671
[TBL] [Abstract][Full Text] [Related]
16. Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition.
Zhu L; Giunzioni I; Tavori H; Covarrubias R; Ding L; Zhang Y; Ormseth M; Major AS; Stafford JM; Linton MF; Fazio S
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1483-95. PubMed ID: 27365402
[TBL] [Abstract][Full Text] [Related]
17. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.
Potteaux S; Combadière C; Esposito B; Lecureuil C; Ait-Oufella H; Merval R; Ardouin P; Tedgui A; Mallat Z
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1858-63. PubMed ID: 16763157
[TBL] [Abstract][Full Text] [Related]
18. Myeloid β-Catenin Deficiency Exacerbates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice.
Wang F; Liu Z; Park SH; Gwag T; Lu W; Ma M; Sui Y; Zhou C
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1468-1478. PubMed ID: 29724817
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-specific IκB kinase β deficiency decreases atherosclerosis in low-density lipoprotein receptor-deficient mice.
Park SH; Sui Y; Gizard F; Xu J; Rios-Pilier J; Helsley RN; Han SS; Zhou C
Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2869-76. PubMed ID: 23023371
[TBL] [Abstract][Full Text] [Related]
20. Myeloid interferon-γ receptor deficiency does not affect atherosclerosis in LDLR(-/-) mice.
Boshuizen MC; Neele AE; Gijbels MJ; van der Velden S; Hoeksema MA; Forman RA; Muller W; Van den Bossche J; de Winther MP
Atherosclerosis; 2016 Mar; 246():325-33. PubMed ID: 26828750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
